Rhizomelic Chondrodysplasia Punctata

This is a specific type of Chondrodysplasia Punctata. It's the most severe form, usually inherited from both parents. It causes short, bowed legs and affects the growth of the bones in the upper part of the legs (the 'rhizomelic' part). It's caused by a problem with how the body makes certain fats needed for bone growth.

Condition

What people with Rhizomelic Chondrodysplasia Punctata report

Every report comes from a Lived member, sent anonymously.

NameHow it went

No reports yet

Add what worked for you with the search bar below

About Rhizomelic Chondrodysplasia Punctata

What It Is

Rhizomelic chondrodysplasia punctata (RCDP) is a rare inherited condition that affects the development of many parts of the body, including the bones, eyes, brain and lungs. Its name describes two hallmark skeletal features. Rhizomelic means the bones closest to the body, the upper arms and thighs, are noticeably short. Chondrodysplasia punctata means that the growing ends of the bones contain small spots of calcium, a stippled pattern that shows up on x-rays in infancy. Most babies with RCDP also have clouding of the lenses of the eyes (cataracts), stiff joints that do not fully straighten (contractures), slow growth and distinctive facial features such as a flat midface and a small upturned nose. Development is usually severely delayed, and seizures and breathing problems are common. Severity varies a great deal. In the classic form, which is the most common, children have profound developmental and physical disability and serious lung problems from early life. In the nonclassic, milder form, features appear later and are less severe, and many children learn to walk and communicate. RCDP affects fewer than 1 in 100,000 people.

Causes & Risk Factors

RCDP is caused by changes in genes that peroxisomes need to do their work. Peroxisomes are tiny compartments inside cells that break down certain fats and build others, including plasmalogens, a type of fat found in cell membranes throughout the body, especially in nerves and developing bone. In RCDP, the body cannot make enough plasmalogens, and this shortage is thought to drive the condition's effects. Children with very low plasmalogen levels tend to have the classic form, while those who make some plasmalogen usually have milder disease. Five types are recognized, named by the gene involved. Type 1, caused by changes in a gene called PEX7, is the most common. Type 1 also causes a buildup of phytanic acid, a fat that comes from the diet, which matters for treatment. RCDP is inherited in an autosomal recessive pattern: a child is affected only when they inherit a changed copy of the gene from each parent. Parents who each carry one changed copy are usually healthy and often have no family history. When both parents are carriers, each pregnancy has a 1 in 4 (25%) chance of an affected child. Nothing a parent did during pregnancy causes RCDP.

How It's Diagnosed

RCDP is often suspected at birth or in the first months of life, when a baby has short upper arms and thighs, cataracts or the typical facial features. X-rays showing stippling at the ends of the bones and short upper limb bones support the diagnosis. Confirmation comes from a blood test showing low plasmalogen levels in red blood cells, together with genetic testing to find the gene responsible. The blood test also helps separate RCDP from look-alikes. Other forms of chondrodysplasia punctata, including X-linked types and stippling caused by exposure to the blood thinner warfarin during pregnancy, have different causes, usually a different pattern of features (for example, uneven rather than symmetric limb shortening) and normal plasmalogen levels. Zellweger spectrum disorder, a broader peroxisome condition, raises blood levels of very long chain fatty acids, which are normal in RCDP. Plasmalogen levels and the specific gene change can also help indicate whether a child has the classic or milder form. Children with milder RCDP may not be diagnosed until later in childhood, when developmental delay or cataracts become apparent. Once a family's gene changes are known, carrier testing for relatives and testing in future pregnancies are possible.

Treatment Options

There is no cure for RCDP, and no treatment yet replaces the missing plasmalogens. Care focuses on preventing complications, easing symptoms and supporting the child's comfort, development and family life. Because the condition affects many body systems, care is usually coordinated by a team that can include genetics, neurology, lung, eye, orthopedic, feeding and developmental specialists. Breathing and feeding are often the central concerns. Many children have trouble feeding safely and can inhale food or liquid into the lungs (aspiration), which leads to chest infections. A feeding tube can provide nutrition more safely, and chest physiotherapy and regular lung checks help protect the lungs. Seizures are treated with anti-seizure medicines chosen by a neurologist. Other treatments address specific problems: surgery to remove cataracts and improve vision, and physical therapy and sometimes orthopedic surgery for contractures and bone deformities. Children with the milder form benefit from early intervention, special education and communication support. In type 1, a diet low in phytanic acid is used to keep this fat from building up, guided by the metabolic care team. Researchers are developing treatments aimed at the underlying plasmalogen shortage. One synthetic plasmalogen precursor, a building block the body could turn into plasmalogens, has completed early safety testing in healthy adults, but no such treatment has yet been shown to help people with RCDP.

What to Expect

The outlook depends mostly on whether a child has the classic or milder form. In classic RCDP, most children do not progress beyond the developmental skills of a typical 6-month-old, although many learn to smile, laugh and recognize familiar people. Growth is very slow, and children usually need full support with feeding, movement and daily care. Life expectancy is shortened: many children with the classic form live into early or mid childhood, and survival past age 10 is uncommon. Breathing problems and chest infections are the most common cause of death. Survival has improved as diagnosis and supportive care have improved, and outcomes vary from child to child. Children with the milder form often walk and develop basic spoken or nonverbal communication, though learning difficulties, behavioral challenges, seizures and joint stiffness are common. Some people with milder RCDP have lived into adolescence and adulthood. For any form, regular follow-up helps catch problems early. Typical monitoring includes growth and nutrition checks, eye and hearing exams, heart and lung assessment, and watching for seizures and narrowing of the spinal canal in the neck (spinal stenosis). In type 1, yearly phytanic acid levels show whether the diet is keeping this fat in check. Caring for a child with RCDP is demanding, and families often benefit from social work support, help arranging care services, and connection with other RCDP families through patient organizations.

When to Seek Help

If a baby has short upper arms and thighs, cataracts or stippled bones on an x-ray, ask for a referral to a genetics specialist for evaluation. Parents of a child with RCDP, and their relatives, can ask about genetic counseling before a future pregnancy. Contact the care team promptly if a child with RCDP has a fever, cough, faster breathing than usual or more choking or coughing with feeds, since chest infections can worsen quickly. Also call promptly about new or more frequent seizures, or new weakness, loss of skills or a change in bladder control, which can signal pressure on the spinal cord. Call 911 if a child is struggling to breathe, is breathing much harder than usual and cannot settle, or stops breathing. Also call 911 if a seizure lasts longer than 5 minutes, or seizures keep coming without the child waking up in between, unless the neurologist has given a seizure action plan that says otherwise.

Questions to Ask Your Doctor

  1. 1.Does my child have the classic or the milder form, and what does that suggest about the years ahead?
  2. 2.Which specialists should be on my child's care team, and who will coordinate their care?
  3. 3.What can we do to lower the risk of aspiration and chest infections, and would a feeding tube help?
  4. 4.How will we monitor for seizures, spinal stenosis and other complications, and how often?
  5. 5.What genetic counseling and testing are available for our family and for future pregnancies?

Last reviewed • Oct 2026

Educational content, not medical advice.